DISEASE SCANNER
Global Incurable Diseases Tracker
Nasopharyngeal Cancer
Cancer arising from the nasopharynx, the area behind the nose and above the back of the throat. Strongly associated with Epstein-Barr virus (EBV), genetic factors, and certain dietary habits (salted fish). Common in Southeast Asia and North Africa.
130.0K
77
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Nasopharyngoscopy
- 2Biopsy
- 3MRI/CT of head/neck
- 4PET-CT (staging)
- 5EBV DNA testing
- 6Complete blood count
- 7Liver function tests
Prognosis
Generally good due to radiosensitivity. 5-year survival: Stage I: >90%, Stage II: 80%, Stage III: 75%, Stage IV: 60%. EBV DNA levels predict prognosis and recurrence.
Prevention
- Limit salted fish consumption
- Avoid smoking
- Limit alcohol
- EBV management (research ongoing)
- Screening in high-risk populations
Research Status
Radiation therapy is primary treatment. Chemoradiation for locally advanced. Excellent response to radiation due to undifferentiated histology. Immunotherapy for recurrent/metastatic. EBV DNA monitoring for recurrence detection.
Affected Countries
Sources
- https://www.cancer.org/cancer/types/nasopharyngeal-cancer.html
- https://www.cancer.gov/types/head-and-neck/patient/nasopharyngeal-treatment-pdq
- https://www.mayoclinic.org/diseases-conditions/nasopharyngeal-carcinoma
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.